Michal Abrahamowicz
Research Scientist, Biostatistics, PhD
Appointments
- James McGill Professor of Biostatistics, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University
- Medical Scientist, Division of Clinical Epidemiology, Research Institute – McGill University Health Centre
Research Interests
- Biostatistics
- Survival analysis
- Pharmacoepidemiology
- Clinical epidemiology
- Epidemiologic methods
- Longitudinal analysis
- Non-communicable disease epidemiology
Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has also developed new methods to control for different sources of bias in observational studies.
His collaborative research includes arthritis, cardiovascular, cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes more than 35 faculty members from 14 universities across Canada. He is the co-chair of the international STRATOS initiative for improving analyses of observational studies (www.stratos-initiative.org). In 2010-14 he was a member of the Executive Committee of the International Society for Clinical Biostatistics (ISCB).Learn more
Recent News Coverage

More Support Needed for Patients with Rheumatoid Arthritis Looking to Start Families
New study highlights need for more support for female patients with rheumatoid arthritis and their partners when it comes to family planning and reproductive decisions.

New Research Ties Popular Pain Killer to Serious Health Risks
Research finds people with osteoarthritis who started taking tramadol were at a 20-50% greater risk of mortality, 70% greater risk of blood clots, and 40-60% greater risk of hip fractures compared to those who started using drugs like aspirin or ibuprofen.

Research Points to Common Antimalarial Medication to Reduce Risk of Cardiovascular Events in Patients with Lupus and Rheumatoid Arthritis
New research ties hydroxychloroquine use by patients with systemic lupus erythematosus and rheumatoid arthritis to lower risk of cardiovascular events like heart attack, stroke and blood clots in the legs and lungs.
2022 ARThritis Soirée – Get Your Tickets Today!
Arthritis Research Canada is thrilled to announce the return of its signature fundraising event, the ARThritis Soirée, to The Roof, Hotel Vancouver on May 26, 2022 at 7 PM. Early bird tickets available now!

Research Finds Ways to Curb Osteoarthritis Pandemic
It is estimated that by 2040, 12 million Canadians will be living with osteoarthritis. But new research points to three interventions to reduce the health burden of this debilitating type of arthritis in Canada.
Arthritis Research Canada, Senior Scientist, Dr. Antonio Aviña-Zubieta Appointed Head of the UBC Division of Rheumatology
Arthritis Research Canada is proud to announce the recent appointment of Senior Scientist, Dr. Antonio Aviña-Zubieta, as the Head of the Division of Rheumatology at the University of British Columbia.
Study Confirms Importance of Self-Management Program for Adolescents with Arthritis
New research reveals self-management programs can help adolescents living with juvenile idiopathic arthritis manage their disease as they enter adulthood.
Osteoarthritis Prevention Program Aims to Stop Lifetime of Pain
Our scientists have developed a unique program designed to prevent osteoarthritis after a sport-related knee injury.
Making it Work™: Unique Program Seeks to Keep People with Arthritis in the Workforce
Arthritis Research Canada’s scientists have developed a one-of-a-kind program, called Making it Work™, to help people with inflammatory types of arthritis and osteoarthritis keep their jobs without sacrificing their health.
Arthritis Researchers Develop New Way to Identify Osteoarthritis Severity
Arthritis Research Canada scientists have created a new grading scale to measure the severity of osteoarthritis in patients. The scale will facilitate more detailed research and may eventually lead to breakthroughs in treatments and prevention strategies.